Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IDX184 with Peg-IFN/RBV in Treatment-Naïve Genotype 1 Chronic Hepatitis C
NCT01371604Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Jul 2011
- Primary completion
- Mar 2013
01
Overview
A Phase 2 trial of IDX184 in hepatitis C virus infection, sponsored by Merck & Co.. Started Jul 2011; status: completed.
02
Drugs
IDX184
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on NCT01371604.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01371604.